Diffusion Pharmaceuticals CEO Robert Cobuzzi receives $817K in 2020
Diffusion Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: April 30, 2021
Diffusion Pharmaceuticals reported fiscal year 2020 executive compensation information on April 30, 2021.
In 2020, five executives at Diffusion Pharmaceuticals received on average a compensation package of $481K, a 17% increase compared to previous year.
Average pay of disclosed executives at Diffusion Pharmaceuticals
Robert J. Cobuzzi, Jr., Chief Executive Officer, received $817K in total. 63% of Cobuzzi's compensation, or $512K, was in option awards. Cobuzzi also received $68K in bonus, $129K in salary, $50K in stock awards, as well as $59K in other compensation.
William K. Hornung, Chief Financial Officer, received a compensation package of $540K, which increased by 52% compared to previous year. 55% of the compensation package, or $298K, was in salary.
David G. Kalergis, Chief Executive Officer, earned $481K in 2020, a 1% increase compared to previous year.
Christopher D. Galloway, Chief Medical Officer, received $300K in 2020.
William R. Elder, General Counsel, earned $266K in 2020.
Related executives
Robert Cobuzzi
Diffusion Pharmaceuticals
Chief Executive Officer
William Hornung
Diffusion Pharmaceuticals
Chief Financial Officer
Christopher Galloway
Diffusion Pharmaceuticals
Chief Medical Officer
William Elder
Diffusion Pharmaceuticals
General Counsel
David Kalergis
Diffusion Pharmaceuticals
Chief Executive Officer
You may also like
Source: SEC filing on April 30, 2021.